Isolation and structure-bioactivity characterization of glycosylated N-pro-opiomelanoconin isoforms

Journal of Neuroendocrinology

Volumn 14, Issue 11, 2002, Pages 869-879

  Lu, J ^a   Swinnen, E ^a   Proost, P ^b   De Vreese, B ^c   Vankelecom, H ^a   Denef, C ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Aggregate cell culture; AtT 20 cells; Glycosylation; N terminal POMC; Prolactin mRNA

Indexed keywords

AMINO ACID; BROXURIDINE; CATION; DNA; ISOPROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROLACTIN; PROOPIOMELANOCORTIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATION EXCHANGE; CELL AGGREGATION; CELL POPULATION; CELL STRAIN; CONTROLLED STUDY; CULTURE MEDIUM; DATA ANALYSIS; DEGLYCOSYLATION; DOSE RESPONSE; GEL PERMEATION CHROMATOGRAPHY; HYPOPHYSIS CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCUBATION TIME; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RNA ANALYSIS; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES; BROMODEOXYURIDINE; CELLS, CULTURED; FEMALE; GLYCOSYLATION; MICE; PEPTIDE FRAGMENTS; PITUITARY GLAND, ANTERIOR; PRO-OPIOMELANOCORTIN; PROLACTIN; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0036855474     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2002.00851.x     Document Type: Article

References (62)

1. Seger MA, Bennett HP. Structure and bioactivity of the amino-terminal fragment of pro-opiomelanocortin. J Steroid Biochem 1986; 25: 703-710.
2. Nakanishi S, Kita T, Taii S, Imura H, Numa S. Glucocorticoid effect on the level of corticotropin messenger RNA activity in rat pituitary. Proc Natl Acad Sci USA 1977; 74: 3283-3286.
3. Crine P, Gianoulakis C, Seidah NG, Gossard F, Pezalla PD, Lis M, Chretien M. Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia. Proc Natl Acad Sci USA 1978; 75: 4719-4723.
4. Roberts JL, Phillips M, Rosa PA, Herbert E. Steps involved in the processing of common precursor forms of adrenocorticotropin and endorphin in cultures of mouse pituitary cells. Biochemistry 1978; 17: 3609-3618.
5. Hinman MB, Herbert E. Processing of the precursor to adrenocorticotrophic hormone and beta-lipotropin in monolayer cultures of mouse anterior pituitary. Biochemistry 1980; 19: 5395-5402.
6. Chretien M, Benjannet S, Gossard F, Gianoulakis C, Crine P, Lis M, Seidah NG. From beta-lipotropin to beta-endorphin and 'pro-opiomelanocortin'. Can J Biochem 1979; 57: 1111-1121.
7. Mains RE, Eipper BA. Synthesis and secretion of corticotropins, melanotropins, and endorphins by rat intermediate pituitary cells. J Biol Chem 1979; 254: 7885-7894.
8. Seidah NG, Gianoulakis C, Crine P, Lis M, Benjannet S, Routhier R, Chretien M. In vitro biosynthesis and chemical characterization of beta-lipotropin, gamma-lipotropin, and beta-endorphin in rat pars intermedia. Proc Natl Acad Sci USA 1978; 75: 3153-3157.
9. Crine P, Gossard F, Seidah NG, Blanchette L, Lis M, Chretien M. Concomitant synthesis of beta-endorphin and alpha-melanotropin from two forms of pro-opiomelanocortin in the rat pars intermedia. Proc Natl Acad Sci USA 1979; 76: 5085-5089.
10. Gianoulakis C, Seidah NG, Routhier R, Chretien M. Biosynthesis and characterization of adrenocorticotropic hormone, alpha-melanocyte-stimulating hormone, and an NH2-terminal fragment of the adrenocorticotropic hormone/beta-lipotropin precursor from rat pars intermedia. J Biol Chem 1979; 254: 11903-11906.
11. 14C-labelled amino acids into corticotrophin-like intermediate lobe peptide and alpha-melanocyte-stimulating hormone by the rat pituitary neurointermediate lobe in vitro, and the identification of four new pars intermedia peptides. J Endocrinol 1976; 70: 197-205.
12. Scott AP, Ratcliffe JG, Rees LH, Landon J, Bennett HP, Lowry PJ, McMartin C. Pituitary peptide. Nature New Biol 1973; 244: 65-67.
13. DeBold CR, Menefee JK, Nicholson WE, Orth DN. Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Mol Endocrinol 1988; 2: 862-870.
14. Texier PL, de Keyzer Y, Lacave R, Vieau D, Lenne F, Rojas-Miranda A, Verley JM, Luton JP, Kahn A, Bertagna X. Proopiomelanocortin gene expression in normal and tumoral human lung. J Clin Endocrinol Metab 1991; 73: 414-420.
15. Bronstein DM, Schafer MK, Watson SJ, Akil H. Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA. Brain Res 1992; 587: 269-275.
16. Pintar JE, Schachter BS, Herman AB, Durgerian S, Krieger DT. Characterization and localization of proopiomelanocortin messenger RNA in the adult rat testis. Science 1984; 225: 632-634.
17. Crosby SR, Stewart MF, Farrell WE, Gibson S, White A. Comparison of ACTH and ACTH precursor peptides secreted by human pituitary and lung tumour cells in vitro. J Endocrinol 1990; 125: 147-152.
18. De LV, Melino G, Knight RA, Pierotti AR, Cohen P. Modulation of POMC expression in human neuroectodermal cells. Biochem Biophys Res Commun 1993; 197: 1402-1409.
19. Amemiya Y, Takahashi A, Dores RM, Kawauchi H. Sturgeon proopiomelanocortin has a remnant of gamma-melanotropin. Biochem Biophys Res Commun 1997; 230: 452-456.
20. Amemiya Y, Takahashi A, Meguro H, Kawauchi H. Molecular cloning of lungfish proopiomelanocortin cDNA. Gen Comp Endocrinol 1999; 115: 415-421.
21. Hilario E, Lihrmann I, Vaudry H. Characterization of the cDNA encoding proopiomelanocortin in the frog Rana ridibunda. Biochem Biophys Res Commun 1990; 173: 653-659.
22. Berghman LR, Devreese B, Verhaert P, Gerets H, Arckens L, Vanden Broeck J, Van Beeumen J, Vaudry H, Vandesande F. The molecular characterisation of chicken pituitary N-terminal pro-opiomelanocortin (POMC). Mol Cell Endocrinol 1998; 142: 119-130.
23. Seidah NG, Rochemont J, Hamelin J, Lis M, Chretien M. Primary structure of the major human pituitary pro-opiomelanocortin NH2-terminal glycopeptide. Evidence for an aldosterone-stimulating activity. J Biol Chem 1981; 256: 7977-7984.
24. Bennett HP, Seidah NG, Benjannet S, Solomon S, Chretien M. Reinvestigation of the disulfide bridge arrangement in human pro-opiomelanocortin N-terminal segment (hNT 1-76). Int J Pept Protein Res 1986; 27: 306-313.
25. Lariviere N, Seidah NG, De Serres G, Rochemont J, Chretien M. Two glycosylation sites on the N-terminal segment of porcine pars distalis pro-opiomelanocortin. FEBS Lett 1980; 122: 279-282.
26. Siciliano RA, Morris HR, McDowell RA, Azadi P, Rogers ME, Bennett HP, Dell A. The Lewis x epitope is a major non-reducing structure in the sulphated N-glycans attached to Asn-65 of bovine pro-opiomelanocortin. Glycobiology 1993; 3: 225-239.
27. Siciliano RA, Morris HR, Bennett HP, Dell A. O-glycosylation mimics N-glycosylation in the 16-kDa fragment of bovine pro-opiomelanocortin. The major O-glycan attached to Thr-45 carries S04-4Ga1NAc beta 1-4G1cNAc beta 1 -, which is the archetypal non-reducing epitope in the N-glycans of pituitary glycohormones. J Biol Chem 1994; 269: 910-920.
28. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993; 90: 8856-8860.
29. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, De Watson SJI, Valle J, Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993; 268: 8246-9250.
30. 2+ concentration? J Neuroendocrinol 1999; 11: 171-179.
31. Tilemans D, Ramaekers D, Andries M, Denef C. Effect of POMC (1-76), its C-terminal fragment gamma3-MSH and anti-POMC (1-76) antibodies on DNA replication in lactotrophs in aggregate cell cultures of immature rat pituitary. J Neuroendocrinol 1997; 9: 627-637.
32. Bert C, Vande Vijver V, Andries M, Verhaert P, Proost P, De Vreese B, Van Beeumen J, Vankelecom H, Denef C. Production of recombinant rat proopiomelanocortin 1-74 and characterization of its mitogenic action on pituitary lactotrophs. Mol Cell Endocrinol 1999; 154: 111-122.
33. Bennett HP. Biosynthetic fate of the amino-terminal fragment of pro-opiomelanocortin within the intermediate lobe of the mouse pituitary. Peptides 1986: 7: 615-622.
34. Birch NP, Estivariz FE, Bennett HP, Loh YP. Differential glycosylation of N-POMC1-77 regulates the production of gamma 3-MSH by purified proopiomelanocortin converting enzyme. A possible mechanism for tissue-specific processing. FEBS Lett 1991; 290: 191-194.
35. Estivariz FE, Morano MI, Carino M, Jackson S, Lowry PJ. Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary. J Endocrinol 1988; 116: 207-216.
36. Estivariz FE, Carino M, Lowry PJ, Jackson S. Further evidence that N-terminal pro-opiomelanocortin peptides are involved in adrenal mitogenesis. J Endocrinol 1988; 116: 201-206.
37. Lowry PJ, Silas L, McLean C, Linton EA, Estivariz FE. Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 1983; 306: 70-73.
38. Cathiard AM, Durand P, Seidah MG, Chretien M, Saez JM. Effects of several pro-opiomelanocortin derived pepticles on steroidogenesis in ovine and bovine adrenal cells. J Steroid Biochem 1985; 23: 185-190.
39. Durand P, Cathiard AM, Seidah NG, Chretien M, Saez JM. Effects of proopiomelanocortin-derived peptides, methionine-enkephalin and forskolin on the maturation of ovine fetal adrenal cells in culture. Biol Reprod 1984; 31: 694-704.
40. Lis M, Hamet P, Gutkowska J, Maurice G, Seidah NG, Lariviere N, Chretien M, Genest J. Effect of N-terminal portion of pro-opiomelanocortin on aldosterone release by human adrenal adenoma in vitro. J Clin Endocrinol Metab 1981; 52: 1053-1056.
41. Pedersen RC, Brownie AC. Adrenocortical response to corticotropin is potentiated by part of the amino-terminal region of pro-corticotropin/endorphin. Proc Natl Acad Sci USA 1980; 77: 2239-2243.
42. Pham-Huu-Trung MT, Bogyo A, Leneuve P, Girard F. Compared effects of ACTH, angiotensin II and POMC peptides on isolated human adrenal cells. J Steroid Biochem 1986; 24: 345-348.
43. Schiffrin EL, Chretien M, Seidah NG, Lis M, Gutkowska J, Cantin M, Genest J. Response of human aldosteronoma cells in culture to the N-terminal glycopeptide of pro-opiomelanocortin and gamma 3-MSH. Horm Metab Res 1983; 15: 181-184.
44. Sharp B, Sowers JR. Adrenocortical response to corticotropin is inhibited by gamma 3-MSH antisera in normotensive and spontaneously hypertensive rats. Biochem Biophys Res Common 1983; 110: 357-363.
45. Bicknell AB, Lomthaisong K, Woods RJ, Hutchinson EG, Bennett HP, Gladwell RT, Lowry PJ. Characterization of a scrine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 2001; 105: 903-912.
46. Strand FL. New vistas for melanocortins. Finally, an explanation for their pleiotropic functions. Ann NY Acad Sci 1999; 897: 1-16.
47. Tilemans D, Andries M, Proost P, Devreese B, Van Beeumen J, Denef C. In vitro evidence that an 11-kilodalton N-terminal fragment of proopiomelanocortin is a growth factor specifically stimulating the development of lactotrophs in rat pituitary during postnatal life. Endocrinology 1994; 135: 168-174.
48. Van Bael A, Vande Vijver V, Devreese B, Van Beeumen J, Denef C. N-terminal 10- and 12-kDa POMC fragments stimulate differentiation of lactotrophs. Peptides 1996; 17: 1219-1228.
49. Bennett HP. Use of ion-exchange Sep-Pak cartridges in the batch fractionation of pituitary peptides. J Chromatogr 1986; 359: 383-390.
50. Boyd VL, Bozzini M, Zen G, Noble RL, Mattaliano RJ. Sequencing of peptides and proteins from the carboxy terminus. Anal Biochem 1992; 206: 344-352.
51. Dupont DR, Bozzini M, Boyd VL. The alkylated thiohydantoin method for C-terminal sequence analysis. EXS 2000; 88: 119-131.
52. Samyn B, Van der Hardeman KEJ, Van Beeumen J. Applicability of the alkylation chemistry for chemical C-terminal protein sequence analysis. Anal Chem 2000; 72: 1389-1399.
53. Orlando C, Pinzani P, Pazzagli M. Developments in quantitative PCR. Clin Chem Lab Med 1998; 36: 255-269.
54. Fink L, Seeger W, Ermert L, Hanze J, Stahl U, Grimminger F, Kummer W, Bohle RM. Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Med 1998; 4: 1329-1333.
55. Eipper BA, Mains RE. Existence of a common precursor to ACTH and endorphin in the anterior and intermediate lobes of the rat pituitary. J Supramol Struct 1978; 8: 247-262.
56. Drouin J, Goodman HM. Most of the coding region of rat ACTH beta-LPH precursor gene lacks intervening sequences. Nature 1980; 288: 610-613.
57. Uhler M, Herbert E. Complete amino acid sequence of mouse pro-opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J Biol Chem 1983; 258: 257-261.
58. Affolter HU, Reisine T. Corticotropin releasing factor increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells. J Biol Client 1985; 260: 15477-15481.
59. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-1397.
60. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II. Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Endocrinology 1997; 138: 1930-1934.
61. Shibasaki T, Ling N, Guillemin R. Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides. Nature 1980; 285: 416-417.
62. Arey BJ, Stevis PE, Deecher DC, Shen ES, Frail DE, Negro-Vilar A, Lopez FJ. Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol Endocrinol 1997; 11: 517-526.